Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT01043627Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)
NCT04050449Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
NCT04870333PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
NCT03481725Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study
NCT05231122Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
NCT02893995Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
NCT01560624Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
NCT02603068Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT03367312Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
NCT0006951112 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
NCT05245006PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
NCT01746485Three Times Daily Dosing of UT-15C
NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
NCT01042158A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
NCT04090866Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
NCT00969722A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients
NCT04865393Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function
NCT03098030Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
NCT02279745Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
NCT04005469Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
NCT02573896Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
NCT01557647Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
NCT00262106Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
NCT04868292Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers
NCT00848107Open-Label Study of Oral Treprostinil in Digital Ulcers
NCT00494533Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
NCT00004497Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
NCT00643604Rapid Switch From Flolan to Remodulin in the Outpatient Clinic
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT05421897Rapid Administration Pilot for Infusing Dinutuximab
NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
NCT03037580Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
NCT03794583Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT00060996Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
NCT02360345Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly
NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
NCT01321073DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NCT00963027Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
NCT00760916FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT05943535Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
NCT05776225Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
NCT01477333Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
NCT01273922Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida
NCT01560637An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
NCT03626688A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT05735249A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects
NCT01172496A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers
NCT03012646Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD